overweight or obesity lifestyle intervention, HIV, overweight, obesity, antiretroviral therapy
Conditions
Interventions
The primary outcome of the study was the change in body weight and body composition at 6 months. Weight change was assessed as both the amount lost from baseline and the percentage of baseline body w
Experimental Behavioral,No Intervention No treatment
counselling group,control group
Sponsors
Addis Ababa University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. The study were enrolled PLWH with overweight or obese, aged 18-65 years 2. They had started combination antiretroviral therapy following the implementation of the test-and-treat strategy in Ethiopia and received antiretrovirals for at least 12 months 3. Maintained viral suppression, and were free of opportunistic infections during the intervention. 4. Eligible participants who had a baseline physical activity level of less than 600 metabolic equivalents in minutes per week
Exclusion criteria
Exclusion criteria: 1. The participants who had undergone formal dietary or physical activity counselling or engaged in organized nutritional and physical activity programs at baseline of the study. 2. Individuals with a history of pulmonary or cardiac complications, neurological problems, or musculoskeletal disorders were excluded from the study. 3. The individuals with confirmed thyroid disease, uncontrolled hypertension, physical conditions that restrict the ability to engage in physical activity, pregnancy at any point during the study, and those with chronic liver and/or renal diseases. 4. Additionally, participants who are undergoing lent or other fasting practices at any point during the study and those failing to meet the inclusion criteria were also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight loss and change in body composition at baseline and after 6 months by using previously validated bioelectrical impedance(BIA). BIA was employed via an Omron Body Composition Monitor with Scale (Omron HBF-514C analyzer, Omron healthcare Inc., Japan) | — |
Secondary
| Measure | Time frame |
|---|---|
| at least 3% weight loss at baseline and after 6 months percent weight loss: ([weight at 6 months minus weight at baseline]/weight at baseline)x100 | — |
Countries
Ethiopia
Contacts
Public ContactAgete Tadewos Hirigo
Hawassa University
Outcome results
None listed